Chemours (CC)
(Delayed Data from NYSE)
$43.99 USD
+0.82 (1.90%)
Updated May 27, 2022 04:00 PM ET
After-Market: $43.98 -0.01 (-0.02%) 6:56 PM ET
2-Buy of 5 2
A Value C Growth C Momentum B VGM
Income Statements
Fiscal Year end for The Chemours Company falls in the month of December .
All items in Millions except EPS data.
12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 | |
---|---|---|---|---|---|
Sales | 6,345 | 4,969 | 5,526 | 6,638 | 6,183 |
Cost Of Goods | 4,964 | 3,902 | 4,463 | 4,667 | 4,429 |
Gross Profit | 1,381 | 1,067 | 1,063 | 1,971 | 1,754 |
Selling & Adminstrative & Depr. & Amort Expenses | 705 | 700 | 715 | 788 | 739 |
Income After Depreciation & Amortization | 676 | 367 | 348 | 1,183 | 1,015 |
Non-Operating Income | 185 | 22 | -264 | 167 | 112 |
Interest Expense | 185 | 210 | 208 | 195 | 215 |
Pretax Income | 676 | 179 | -124 | 1,155 | 912 |
Income Taxes | 68 | -40 | -72 | 159 | 165 |
Minority Interest | 0 | 0 | 0 | 1 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 608 | 219 | -52 | 996 | 747 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income | 608 | 219 | -52 | 995 | 746 |
Depreciation Footnote | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,002 | 696 | 668 | 1,478 | 1,301 |
Depreciation & Amortization (Cash Flow) | 326 | 329 | 320 | 295 | 286 |
Income After Depreciation & Amortization | 676 | 367 | 348 | 1,183 | 1,015 |
Earnings Per Share Data | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 |
---|---|---|---|---|---|
Average Shares | 168.70 | 166.35 | 167.25 | 182.57 | 190.98 |
Diluted EPS Before Non-Recurring Items | 4.00 | 1.98 | 2.51 | 5.67 | 3.82 |
Diluted Net EPS | 3.60 | 1.32 | -0.32 | 5.45 | 3.91 |
Fiscal Year end for The Chemours Company falls in the month of December .
All items in Millions except EPS data.
3/31/22 | 12/31/21 | 9/30/21 | 6/30/21 | 3/31/21 | |
---|---|---|---|---|---|
Sales | 1,764.00 | 1,574.00 | 1,680.00 | 1,655.00 | 1,436.00 |
Cost Of Goods | 1,278.00 | 1,181.00 | 1,253.00 | 1,391.00 | 1,139.00 |
Gross Profit | 486.00 | 393.00 | 427.00 | 264.00 | 297.00 |
SG&A, R&D, and Dept/Amort Expenses | 182.00 | 189.00 | 154.00 | 204.00 | 158.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 304.00 | 204.00 | 273.00 | 60.00 | 139.00 |
Non-Operating Income | 17.00 | 140.00 | 3.00 | 31.00 | 11.00 |
Interest Expense | 41.00 | 44.00 | 45.00 | 47.00 | 49.00 |
Pretax Income | 280.00 | 300.00 | 231.00 | 44.00 | 101.00 |
Income Taxes | 46.00 | 68.00 | 17.00 | -22.00 | 5.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 234.00 | 232.00 | 214.00 | 66.00 | 96.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 234.00 | 232.00 | 214.00 | 66.00 | 96.00 |
Earnings Per Share Data | 3/31/22 | 12/31/21 | 9/30/21 | 6/30/21 | 3/31/21 |
---|---|---|---|---|---|
Average Shares | 163.58 | 166.77 | 168.96 | 170.16 | 169.05 |
Diluted EPS Before Non-Recurring Items | 1.46 | 0.81 | 1.27 | 1.20 | 0.71 |
Diluted Net EPS | 1.43 | 1.37 | 1.27 | 0.39 | 0.57 |